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Abstract
Background:  The  low  FODMAP  diet  eliminates  carbohydrates  and  fermentable  alcohols  because
they are  not  absorbed  by  the  intestine,  but  are  fermented  by  the  microbiota,  causing  bloating
and ﬂatulence.
Aims:  To  evaluate  the  clinical  response  to  the  low  FODMAP  diet  in  patients  with  the  different
clinical subtypes  of  irritable  bowel  syndrome  (IBS).
Materials  and  methods:  attended  to  at  the  Gastroenterology  Department  in  2014  that  were
diagnosed with  IBS  based  on  the  Rome  III  criteria  were  included  in  the  study.  They  were  man-
aged with  a  low  FODMAP  diet  for  21  days  and  their  response  to  the  symptoms  of  abdominal
pain, bloating,  ﬂatulence,  and  stool  form  pre  and  post-diet  were  evaluated  through  the  visual
analogue scale,  Bristol  scale,  and  patient  overall  satisfaction.  The  results  were  analyzed  by
means, 95%  CI,  and  the  Student’s  t  test.
Results:  Of  the  31  patients  included  in  the  study,  87%  were  women  and  the  mean  age  was
46.48 years.  Distribution  was:  IBS-C  64.5%,  IBS-D  22.6%,  and  IBS-M  12.9%.  The  score  for  pain
was 6.0  (95%  CI  5.04-6.96)  and  the  post-diet  score  was  2.77  (95%  CI  1.60-3.95)  (P<.001).  The
score for  bloating  was  7.10  (95%  CI  6.13-8.06)  and  the  post-diet  score  was  4.19  (95%  CI  2.95-
5.44) (P<.001).  The  score  for  ﬂatulence  was  5.94  (95%  CI  4.79-7.08)  and  the  post-diet  score  was
3.06 (IC95%  1.99-4.14)  (P<.001).  The  pre-diet  Bristol  Scale  result  was  3.68  (95%  CI  3.14-4.22)
and the  post-diet  result  was  4.10  (95%  CI  3.66-4.54)  (P=.1).  The  satisfaction  percentage  was
70.9%.
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Conclusions:  In  this  ﬁrst  study  on  a  Mexican  population  with  IBS,  there  was  signiﬁcant  improve-
ment of  the  main  symptoms,  including  pain,  bloating,  and  ﬂatulence  after  treatment  with  a
low FODMAP  diet.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Respuesta  clínica  en  pacientes  mexicanos  con  síndrome  de  intestino  irritable
tratados  con  dieta  baja  en  carbohidratos  fermentables  (FODMAP)
Resumen
Antecedentes:  La  dieta  baja  en  FODMAP  elimina  hidratos  de  carbono  y  alcoholes  fermenta-
bles porque  éstos  no  son  absorbidos  por  el  intestino  pero  son  fermentados  por  la  microbiota
provocando  distensión  y  ﬂatulencia.
Objetivo:  Evaluar  la  respuesta  clínica  en  pacientes  con  síndrome  de  intestino  irritable  (SII)  en
sus diferentes  variantes  clínicas  a  la  dieta  baja  en  FODMAP.
Materiales  y  métodos: Se  incluyó  a  pacientes  de  la  consulta  de  Gastroenterología,  con  diag-
nóstico de  SII  sobre  la  base  de  los  criterios  de  Roma  III  en  2014,  que  fueron  manejados  por
21 días  con  dieta  baja  en  FODMAP,  evaluando  la  respuesta  de  los  síntomas  de  dolor  abdominal,
distensión,  ﬂatulencia  y  forma  de  las  evacuaciones  pre  y  posdieta  con  escala  visual  análoga,
escala de  Bristol  y  la  satisfacción  global.  Los  resultados  fueron  analizados  con  promedios,  IC
del 95%  y  t  de  Student.
Resultados:  Se  incluyó  a  31  pacientes,  87%  mujeres.  Edad  promedio  (46.48).  La  distribución
fue: SII-E  64.5%,  SII-D  22.6%  y  SII-M  12.9%.  La  puntuación  para  dolor  fue  6.0  (IC  del  95%  5.04-
6.96) y  posdieta  fue  2.77  (IC  del  95%  1.60-3.95)  (p  <  0.001).  Para  distensión  fue  7.10  (IC  del  95%
6.13-8.06) y  posdieta  4.19  (IC  del  95%  2.95-5.44)  (p<  0.001).  Para  ﬂatulencia  5.94  (IC  del  95%
4.79-7.08) y  posdieta  3.06  (IC  del  95%  1.99-4.14)  (p<  0.001).  La  escala  de  Bristol  predieta  fue
3.68 (IC  del  95%  3.14-4.22)  y  posdieta  4.10  (IC  del  95%  3.66-4.54)  (p  =  0.1).  El  porcentaje  de
satisfacción  fue  del  70.9%.
Conclusiones:  En  este  primer  estudio  en  población  mexicana  con  SII  se  observó  mejoría  signi-
ﬁcativa de  los  principales  síntomas  incluyendo  dolor,  distensión  y  ﬂatulencia  tras  una  dieta  baja
FODMAP.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Even  though  many  patients  with  irritable  bowel  syndrome
(IBS)  believe  that  diet  is  an  important  part  of  treatment  and
a  certain  amount  of  success  has  been  obtained  with  empir-
ical  dietary  changes,  it  is  only  recently  that  the  effect  of
certain  speciﬁc  modiﬁcations  in  the  diet  of  these  patients
has  been  studied.1
The  FODMAPs  include  short  chain  carbohydrates,  such  as
fructose  and  lactose,  fructo  and  galacto-oligosaccharides,
such  as  fructans  and  galactans,  and  polyhydric  alcohols,  such
as  sorbitol  and  mannitol.  The  term  fructans  includes  carbo-
hydrates  with  chains  consisting  of  more  than  10  carbons,
called  inulins.2
The  low  FODMAP  diet  excludes  fermentable  fruc-
tans,  oligosaccharides,  disaccharides,  monosaccharides,
and  polyoles.3
It  is  currently  known  that  these  carbohydrates  are  poorly
absorbed  in  the  small  bowel  and  when  they  reach  the
colon  they  are  fermented,  producing  gas  and  bloating.  Their
M
A
cymptom-producing  mechanism  is  due  to  distension,  which
s  a  product  of  their  osmotic  effect  and  rapid  fermentation,
ainly  to  hydrogen.4
Patients  with  functional  gastrointestinal  disorders  usually
resent  with  complaints  related  to  an  excess  of  intesti-
al  gas,  mainly  presenting  as  abdominal  bloating  and
atulence.5
In  recent  studies,  the  low  FODMAP  diet  has  been  shown
o  be  efﬁcacious  in  the  treatment  of  IBS  patients,1,4--12 but
o  studies  have  analyzed  the  efﬁcacy  of  this  approach  in
exican  patients.
The aim  of  our  study  was  to  evaluate  the  clinical  response
o  the  low  FODMAP  diet  in  a  Mexican  population  group  diag-
osed  with  IBS  in  any  of  its  clinical  subtypes.ethods
n  experimental,  comparative,  longitudinal,  prospective,
linical  study  was  conducted.  It  included  patients  seen  at  the
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Table  1  Foods  that  are  prohibited  on  the  low  FODMAP  diet.
Fructose  Lactose  Oligosaccharides  Polyols
Fruit  Apples,  pears,  watermelon,
mango,  raisins
Apples,  pears,  cherries,
peaches,  prunes,
coconut  milk,
watermelon
Vegetables  Onion,  garlic,  asparagus,
Brussels  sprouts,
broccoli,  cabbage
Avocado,  pumpkin,
zucchini,  mushrooms,
cauliﬂower
Dairy products  Whole  milk,  ice  cream,
yoghurt,  soft  cheeses  or
queso  fresco
Grains  and  beans Wheat,  rye,  beans,  fava
beans,  chick  peas,  lentils
Sweeteners  Honey,  high-fructose  corn
syrup,  corn  syrup
Sorbitol,  mannitol
(‘‘light’’  drinks)
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resulting  in  a  slight  improvement  in  stool  form,  but  with  no
statistically  signiﬁcant  difference  (p  =  0.1)  (ﬁg.  1).
Table  2  Study  population  characteristics  and  IBS  subtype
distribution  (IBS-C,  IBS-D,  IBS-M).
Characteristics  n  =  31
Sex
Women  27  87%
Men 4  13%
Mean age  (years)  46.48  (22-77)astroenterology  outpatient  service  of  the  Hospital  Juárez
e  Mexico,  within  the  time  frame  of  March  to  June  2014,
hat  were  diagnosed  with  IBS  and  any  of  its  subtypes,  using
he  Rome  III  criteria:  constipation,  diarrhea,  or  mixed.  The
atients  were  managed  for  21  days  with  a  low  FODMAP  diet
<  0.50  g  per  meal),  based  on  recommendations  published
n  the  medical  literature.  Symptoms  and  stool  forms  before
nd  after  the  diet  were  compared  and  overall  satisfaction
t  the  end  of  the  treatment  was  evaluated.  The  symptoms
nalyzed  were  abdominal  pain,  bloating,  and  ﬂatulence  and
hey  were  measured  through  the  visual  analogue  scale  (VAS)
hat  graded  symptom  severity  on  a  scale  from  0  to  10.  Stool
orm  was  evaluated  using  the  Bristol  Scale  (BS)  (types  1-7).
verall  patient  satisfaction  was  evaluated  through  the  5-
ption  global  satisfaction  scale  (GSS)  (completely  satisﬁed,
oderately  satisﬁed,  slightly  satisﬁed,  neither  satisﬁed  nor
nsatisﬁed,  slightly  unsatisﬁed).
The  patients  were  enrolled  at  an  initial  visit,  registering
ne  day  of  their  usual  diet.  They  were  given  appointments
very  Friday  for  the  ﬁrst  2  weeks  before  beginning  the  low
ODMAP  to  evaluate  the  baseline  VAS  and  BS.  At  their  sec-
nd  week  visit  they  were  given  a  written  diet  (table  1)
hat  included  the  prohibited  foods  for  the  21-day  test
eriod.  The  patients  were  told  to  write  down  their  daily
enu,  which  was  analyzed  by  the  researcher  at  the  control
nterviews.
The  control  of  the  dietary  clinical  response  was  evalu-
ted  once  a  week  during  the  3  weeks  of  treatment,  with
he  patient  ﬁlling  out  the  VAS  and  BS  in  the  presence  of
 researcher,  as  well  as  registering  the  meals  eaten  each
eek.  The  GSS  was  also  analyzed  at  the  appointment  the
nal  week  of  treatment.
The  VAS  was  used  for  the  3  symptoms  to  be  evaluated  and
he  BS  was  employed  for  stool  forms,  as  continuous  numer-
cal  variables.  Means  were  analyzed  as  measures  of  central
endency.  The  difference  between  measurements  before  the
ow  FODMAP  diet  and  after  the  21  days  of  its  application  was
nalyzed  through  the  95%  conﬁdence  interval  for  numerical
ariables  and  the  Student’s  t test  for  paired  samples  of  a
ingle  trend.  Both  calculations  were  made  using  the  2010
xcel  program  for  Mac.esults
 total  of  31  patients  were  included  in  the  study,  87%  of
hich  were  women.  The  mean  age  was  46.4  years  (range:
2-77).  Twenty  patients  (64.5%)  presented  with  the  predom-
nant  IBS-C,  followed  by  7  patients  (22.6%)  with  IBS-D,  and  4
atients  (12.9%)  with  IBS-M  (table  2).  The  mean  body  mass
ndex  of  the  study  patients  was  23.81  kg/m2 (range:  19.1-
9.9  kg/m2),  mean  weight  was  59.96  kg  (range:  49-85  kg),
nd  mean  height  was  1.53  m  (1.50-1.75  m).  The  mean  usual
aloric  intake  exceeded  2,800  kcal.  The  patients’  regular
iet  was  high  in  carbohydrates,  ﬂours,  and  dairy  products
hat  included  foods  such  as  fruits,  juices,  and  sugared  drinks.
airy  intake  was  at  least  twice  a  day  and  ﬂour  intake  at  least
 times  a  day.  The  mean  FODMAP  intake  was  >  300  g  daily.
The  mean  score  for  abdominal  pain  before  the  low
ODMAP  diet  was  6  (95%  CI  = 5.04-6.96)  and  was  2.77  after
he  diet  (95%  CI  =  1.6-3.95)  (p  <  0.001)  (ﬁg.  1).  A  statisti-
ally  signiﬁcant  improvement  was  observed  in  the  scores  for
loating  (7.10  [95%  CI  6.13-8.06]  to  4.19  [95%  CI  2.95-5.44]
p<  0.001])  (ﬁg.  1)  and  ﬂatulence  (5.94  [95%  CI  4.79-7.08]
.06  [95%  CI  1.99-4.14]  [p<  0.001])  (ﬁg.  1).  The  mean  BS  clas-
iﬁcation  before  the  low  FODMAP  diet  was  3.68  units  (95%
I  3.14-4.22)  and  was  4.10  after  the  diet  (95%  CI  3.66-4.54),IBS-D 7  22.7%
IBS-M 4  12.9%
IBS-C 20  64.5%
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Symptom comparison before and after the diet
8∗
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∗
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M –95% CI
SS Dif
No SS Dif
5.04
6.00
6.96
1.60
2.77
3.95
6.13
7.10
8.06
2.95
4.19
5.44
4.79
5.94
7.08
1.99
3.06
4.14
3.14
3.68
4.22
3.66
4.10
4.54M + 95% CI 
M
Pre-diet
 pain 
Post-diet
pain
Pre-diet
bristol scale
Pre-diet
bloating
Post-diet
bloating
Pre-diet
flatulence
Post-diet
flatulence
Post-diet
bristol scale
Figure  1  Graph  showing  the  change  in  abdominal  pain,  bloating,  and  ﬂatulence  evaluated  with  a  10-unit  visual  analogue  scale
and the  stool  form  characteristics  according  to  the  Bristol  Scale,  before  and  after  a  21-day  low  FODMAP  diet.
cally
D
T
M95% CI:  95%  conﬁdence  interval;  M:  mean;  No  SS  Dif:  no  statisti
*SS Dif:  statistically  signiﬁcant  difference  p  <  0.001.
In  relation  to  overall  satisfaction  after  the  low  FODMAP
diet,  70.9%  of  the  patients  had  some  grade  of  satisfaction:
16.1%  said  they  were  slightly  satisﬁed,  25.8%  moderately
satisﬁed,  and  29.0%  completely  satisﬁed.  Of  the  29.1%  that
did  not  express  satisfaction  after  the  low  FODMAP  diet,
16.1%  said  they  had  no  change  (neither  satisﬁed  nor  unsat-
isﬁed)  and  12.9%  stated  that  treatment  was  unsatisfactory
(ﬁg.  2).
t
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80%
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satisfied
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0%
Figure  2  Graph  showing  the  grade  of  overall  satisfaction  in  relat
FODMAP diet  evaluated  with  a  5-point  scale  (5,  completely  satisﬁed;  
nor unsatisﬁed;  1,  slightly  unsatisﬁed). signiﬁcant  difference.
iscussion
he  present  study  sought  to  evaluate  the  clinical  response  in
exican  patients  in  relation  to  the  most  common  IBS  symp-
om  complaints  (abdominal  pain,  bloating,  ﬂatulence,  and
ltered  stool  form)  after  treatment  with  a  low  FODMAP  diet.
Even  though  IBS  is  one  of  the  most  frequent  conditions
onfronting  the  gastroenterologist  in  daily  practice  (with  a
29.1%
16.1%
12.9%
Neither satisfied
nor unsatisfied 
Slightly
unsatisfied
The same or no
satisfaction
ion  to  the  gastrointestinal  symptoms  after  21  days  of  the  low
4,  moderately  satisﬁed;  3,  slightly  satisﬁed;  2,  neither  satisﬁed
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improves gastrointestinal symptoms in patients with irritable
bowel syndrome. Int J Clin Pract. 2013;67:895--903.
10. Staudacher H, Whelan K, Irving P, et al. Comparison of symp-
tom response following advice for a diet low in fermentable
carbohydrates (FODMAPs) versus standard dietary advice in84  
orldwide  incidence  between  10  and  20%  and  an  incidence
n  Mexico  reported  in  different  studies  of  16  to  35%),13,14
reatment  continues  to  be  unsatisfactory.4
An  important  number  of  patients  state  that  certain  foods
rigger  symptoms  of  abdominal  pain,  bloating,  and  ﬂatu-
ence.  Nevertheless,  treatments  focused  on  diet  are  not
 central  part  of  therapy,  mainly  due  to  the  lack  of  evi-
ence  supporting  the  fact  that  the  exclusion  or  reduction  of
 certain  food  would  result  in  improvement.4
In  recent  years,  attention  has  been  given  to  differ-
nt  dietary  modiﬁcations  in  these  patients,  and  one  of
he  diets  that  has  shown  more  efﬁcacy  is  the  diet  low
n  fermentable  fructans,  oligosaccharides,  disaccharides,
onosaccharides,  and  polyols  (the  low  FODMAP  diet).
The  ﬁrst  study  showing  the  beneﬁt  of  this  dietary
pproach  was  a  retrospective  analysis  conducted  on  selected
atients  with  IBS  and  fructose  and  fructans  malabsorp-
ion.  It  was  followed  by  a  double-blind,  randomized  study
ith  a  later  challenge  using  fructose  and  fructans,  alone
r  combined,  in  the  patients  that  had  responded  to  the
iet.  Symptoms  returned  in  4  out  of  5  patients  with  the
e-introduction  of  fructans  and  in  one  out  of  5  patients  in
he  placebo  group.  The  symptoms  were  dose-dependent  and
he  effects  of  fructose  and  fructans  were  synergic.1 In  a
ecent  controlled  and  crossover  study  in  Australia  on  30  IBS
atients,  Halmos  et  al.4 found  that  the  low  FODMAP  diet
fﬁcaciously  reduced  functional  gastrointestinal  symptoms,
ompared  with  a  typical  Australian  diet.  In  another  study,
zpiroz  et  al.5 evaluated  the  response  to  a  low  FODMAP  diet
n  patients  with  ﬂatulence  and  found  signiﬁcant  improve-
ent,  with  a  reduction  of  gas,  compared  with  the  standard
editerranean  diet,  and  they  reported  immediate  beneﬁts
n  relation  to  digestive,  cognitive,  and  emotional  aspects
f  the  patients.  A  study  by  De  Roest  et  al.  compared  the
esponse  of  symptoms  such  as  abdominal  pain  and  ﬂatulence
nd  found  a  76%  response  in  all  the  variables  studied.9
In  our  study,  we  observed  signiﬁcant  improvement  in
he  most  frequent  IBS  symptoms  of  abdominal  pain,  bloat-
ng,  and  ﬂatulence,  with  an  overall  patient  satisfaction  of
0.9%.  These  results  concur  with  those  reported  in  the  cur-
ent  literature.  However,  when  evaluating  stool  form,  we
ound  no  signiﬁcant  improvement  after  treatment.  There-
ore  we  cannot  recommend  this  approach  if  the  aim  is  to
mprove  stool  form  evaluated  through  the  patient-reported
S.
Among  the  strengths  of  our  study  is  the  fact  that  it  was
onducted  at  a  referral  hospital  that  attends  to  patients
rom  different  geographic  areas  of  the  country  (mainly
exico  City,  the  States  of  Mexico,  Hidalgo,  and  Oaxaca),
onforming  a  more  representative  sample  of  the  Mexican
opulation.  Nevertheless,  it  is  important  to  carry  out  a  study
ith  a  larger  sample  that  includes  other  areas  of  Mexico  in
rder  to  conﬁrm  our  ﬁndings.
This  is  the  ﬁrst  study  analyzing  the  low  FODMAP  diet  in  a
exican  population  showing  that  this  therapeutic  approach
ppears  to  be  useful  in  our  environment  for  treating  IBS
ymptoms  related  to  abdominal  pain  or  discomfort,  but  not
or  those  associated  with  changes  in  bowel  habit.
In  conclusion, the  therapeutic  approach  based  on  a  low
ODMAP  diet  in  a  Mexican  population  is  effective  for  the
anagement  of  abdominal  pain,  bloating,  and  ﬂatulence
ssociated  with  IBS.N.  Pérez  y  López  et  al.
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